Home > Result Summaries: Compounds > GSK1360707 Result Summaries: GSK1360707 GSKStudy ID Phase Title Summary (Download) 111914 phase 1 A Single-Blind, Randomised, Placebo-Controlled Study to Evaluate Safety, Tolerability and Pharmacokinetics of Single Oral Escalating Doses of GSK1360707 (0 citation(s)) 112773 phase 1 An open label positron emission tomography study in healthy male subjects to investigate brain DAT and SERT occupancy, pharmacokinetics and safety of single oral doses ofGSK1360707, using 11C- PE2I and 11C-DASB as PET ligands (0 citation(s))
